鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/11 | 3,010 | 3,050 | 2,988 | 3,005 | +13 | +0.4% | 48,800 |
2020/08/07 | 3,085 | 3,085 | 2,987 | 2,992 | -108 | -3.5% | 79,600 |
2020/08/06 | 3,080 | 3,125 | 3,070 | 3,100 | +5 | +0.2% | 41,300 |
2020/08/05 | 3,130 | 3,155 | 3,075 | 3,095 | -80 | -2.5% | 51,700 |
2020/08/04 | 3,300 | 3,320 | 3,155 | 3,175 | -130 | -3.9% | 65,100 |
2020/08/03 | 3,365 | 3,365 | 3,235 | 3,305 | -75 | -2.2% | 69,700 |
2020/07/31 | 3,475 | 3,490 | 3,350 | 3,380 | -150 | -4.2% | 54,700 |
2020/07/30 | 3,450 | 3,530 | 3,440 | 3,530 | +80 | +2.3% | 54,700 |
2020/07/29 | 3,535 | 3,535 | 3,440 | 3,450 | -40 | -1.1% | 40,300 |
2020/07/28 | 3,525 | 3,640 | 3,480 | 3,490 | -10 | -0.3% | 61,300 |
2020/07/27 | 3,465 | 3,500 | 3,435 | 3,500 | +35 | +1% | 53,300 |
2020/07/22 | 3,430 | 3,505 | 3,400 | 3,465 | +35 | +1% | 78,700 |
2020/07/21 | 3,465 | 3,465 | 3,375 | 3,430 | ±0 | ±0% | 41,200 |
2020/07/20 | 3,395 | 3,490 | 3,325 | 3,430 | +130 | +3.9% | 112,700 |
2020/07/17 | 3,325 | 3,330 | 3,245 | 3,300 | +5 | +0.2% | 48,700 |
2020/07/16 | 3,380 | 3,415 | 3,265 | 3,295 | -40 | -1.2% | 83,000 |
2020/07/15 | 3,270 | 3,335 | 3,260 | 3,335 | +120 | +3.7% | 101,000 |
2020/07/14 | 3,160 | 3,235 | 3,155 | 3,215 | +60 | +1.9% | 59,900 |
2020/07/13 | 3,140 | 3,165 | 3,105 | 3,155 | +55 | +1.8% | 59,500 |
2020/07/10 | 3,140 | 3,170 | 3,100 | 3,100 | +15 | +0.5% | 52,200 |
2020/07/09 | 3,110 | 3,120 | 3,055 | 3,085 | +10 | +0.3% | 52,400 |
2020/07/08 | 3,040 | 3,110 | 3,040 | 3,075 | +35 | +1.2% | 49,700 |
2020/07/07 | 3,055 | 3,060 | 3,010 | 3,040 | +20 | +0.7% | 52,200 |
2020/07/06 | 3,020 | 3,050 | 2,993 | 3,020 | ±0 | ±0% | 36,300 |
2020/07/03 | 3,005 | 3,025 | 2,968 | 3,020 | +52 | +1.8% | 30,900 |
2020/07/02 | 3,060 | 3,060 | 2,945 | 2,968 | -57 | -1.9% | 72,900 |
2020/07/01 | 3,145 | 3,145 | 3,020 | 3,025 | -75 | -2.4% | 52,100 |
2020/06/30 | 3,090 | 3,150 | 3,055 | 3,100 | +70 | +2.3% | 48,400 |
2020/06/29 | 3,095 | 3,095 | 2,976 | 3,030 | -60 | -1.9% | 40,800 |
2020/06/26 | 3,090 | 3,100 | 3,015 | 3,090 | +40 | +1.3% | 39,000 |
2020/06/25 | 3,070 | 3,110 | 3,030 | 3,050 | -15 | -0.5% | 37,500 |
2020/06/24 | 3,130 | 3,135 | 3,060 | 3,065 | +5 | +0.2% | 25,800 |
2020/06/23 | 3,010 | 3,080 | 2,991 | 3,060 | +60 | +2% | 37,200 |
2020/06/22 | 2,995 | 3,025 | 2,941 | 3,000 | +7 | +0.2% | 26,900 |
2020/06/19 | 3,050 | 3,050 | 2,946 | 2,993 | -57 | -1.9% | 118,400 |
2020/06/18 | 3,120 | 3,140 | 3,035 | 3,050 | -35 | -1.1% | 70,400 |
2020/06/17 | 3,185 | 3,205 | 3,075 | 3,085 | -90 | -2.8% | 61,600 |
2020/06/16 | 3,135 | 3,195 | 3,085 | 3,175 | +95 | +3.1% | 104,400 |
2020/06/15 | 3,120 | 3,190 | 3,080 | 3,080 | -25 | -0.8% | 82,500 |
2020/06/12 | 3,070 | 3,135 | 3,060 | 3,105 | -50 | -1.6% | 51,300 |
2020/06/11 | 3,250 | 3,250 | 3,125 | 3,155 | -110 | -3.4% | 34,100 |
2020/06/10 | 3,285 | 3,395 | 3,205 | 3,265 | +45 | +1.4% | 85,000 |
2020/06/09 | 3,150 | 3,230 | 3,115 | 3,220 | +130 | +4.2% | 54,300 |
2020/06/08 | 3,155 | 3,155 | 3,075 | 3,090 | -60 | -1.9% | 32,100 |
2020/06/05 | 3,180 | 3,180 | 3,105 | 3,150 | +5 | +0.2% | 25,600 |
2020/06/04 | 3,195 | 3,195 | 3,105 | 3,145 | -20 | -0.6% | 29,600 |
2020/06/03 | 3,230 | 3,230 | 3,125 | 3,165 | -40 | -1.2% | 40,100 |
2020/06/02 | 3,250 | 3,250 | 3,190 | 3,205 | -15 | -0.5% | 25,500 |
2020/06/01 | 3,295 | 3,295 | 3,185 | 3,220 | -25 | -0.8% | 35,000 |
2020/05/29 | 3,195 | 3,315 | 3,195 | 3,245 | +55 | +1.7% | 75,500 |
1151~
1200
件表示中 / 3685件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 451,000円 | +7.1% | -35.0% | 2.66% | 37.29倍 | 1.04倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
サンバイオ | 228,200円 | - | - | 0.00% | - | 105.70倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
東和薬品 | 256,200円 | +15.0% | -7.3% | 2.73% | 8.41倍 | 0.79倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 233,400円 | +14.2% | +41.0% | 1.97% | 11.43倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 307,500円 | +3.0% | +27.5% | 2.60% | 19.47倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
市場注目の銘柄
チャート関連のコラム